Development of Cancer in Patients With Heart Failure: How Systemic Inflammation Can Lay the Groundwork
In the last decade, cardiologists and oncologists have provided clinical and experimental evidence that cancer, and not only chemotherapeutic agents, can cause detrimental effects on heart structure and function, a consequence that has serious clinical implications for patient management. In paralle...
Main Authors: | Simonetta Ausoni, Giuseppe Azzarello |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2020.598384/full |
Similar Items
-
The role of cardiokines in metabolic heart disease
by: Tu, Vivian Huikang
Published: (2016) -
Identification of a CTRP9 C-Terminal polypeptide capable of enhancing bone-derived mesenchymal stem cell cardioprotection through promoting angiogenic exosome production
by: Demin Liu, et al.
Published: (2021-05-01) -
Are there differences in acute phase inflammation markers regarding the type of heart failure?
by: Jaime Agüero-Ramón-Llin, et al.
Published: (2011-09-01) -
ROLE OF ENDOTOXIN AND SYSTEMIC INFLAMMATION IN CHRONIC HEART FAILURE PATHOGENESIS
by: E. N. Egorova, et al.
Published: (2012-06-01) -
The contribution of implantable cardioverter defibrillators to systemic inflammation in heart failure patients
by: Ozcan Orscelik, et al.
Published: (2019-06-01)